HomeReleases

Releases

Investors Launch Class Action Suit Against Zoetis Over Product Claims
Releases

Investors Launch Class Action Suit Against Zoetis Over Product Claims

Investors who purchased Zoetis Inc. stock between January 14, 2025, and May 6, 2026, face a July 27 deadline to join a class action lawsuit. The litigation alleges the pharmaceutical company misled shareholders regarding the performance and safety of its key veterinary products, including Librela, Apoquel, and Cytopoint.

Lundbeck hits recruitment milestone for broad-spectrum epilepsy trial
Releases

Lundbeck hits recruitment milestone for broad-spectrum epilepsy trial

Lundbeck has finalized patient randomization for DEEp OCEAN, a pivotal Phase III clinical trial testing the investigational molecule bexicaserin. The study targets a wide spectrum of developmental and epileptic encephalopathies, marking a significant step toward addressing a group of severe childhood-onset conditions that currently lack universal treatment options.

Money Talk·Jul 20
A new mission to locate missing Flying Tigers pilots 85 years later
Releases

A new mission to locate missing Flying Tigers pilots 85 years later

Eighty-five years after the American Volunteer Group first took to the skies over China, a new initiative has launched in Nanjing to locate the remains of missing pilots. The project aims to cross-reference international archives to finally identify airmen lost during the fight against fascism in World War II.

Money Talk·Jul 20
Acron Technologies Debuts Unified Identity at Farnborough Airshow
Releases

Acron Technologies Debuts Unified Identity at Farnborough Airshow

Under the backdrop of the 2026 Farnborough International Airshow, Acron Technologies officially unveiled a consolidated corporate identity. The launch marks the first public pivot for the platform, which integrates thirteen specialized aerospace and defense firms into a single, cohesive portfolio designed to streamline mission-critical technology services.

Money Talk·Jul 20
Schall Law Firm Investigates Alibaba Over Anthropic AI Claims
Releases

Schall Law Firm Investigates Alibaba Over Anthropic AI Claims

The Schall Law Firm has launched an investigation into Alibaba Group Holding Limited following allegations that the e-commerce giant illicitly misappropriated core technology from the U.S.-based artificial intelligence company Anthropic, potentially misleading shareholders regarding the integrity of its proprietary systems.

Money Talk·Jul 20
ADMA Biologics Faces Class Action Lawsuit Over Alleged Misconduct
Releases

ADMA Biologics Faces Class Action Lawsuit Over Alleged Misconduct

Investors who held ADMA Biologics stock between August 9, 2024, and March 25, 2026, face a critical deadline as a class action lawsuit moves forward. The DJS Law Group is currently organizing plaintiffs to address allegations that the pharmaceutical company misled the market regarding its financial practices and internal transactions.

AeroVironment Faces Class Action Over SCAR Program Disclosures
Releases

AeroVironment Faces Class Action Over SCAR Program Disclosures

Investors who purchased AeroVironment, Inc. stock between June 25, 2025, and March 10, 2026, face a critical deadline as the Schall Law Firm organizes a class action lawsuit. The litigation targets alleged misrepresentations regarding competitive pressures surrounding the company’s U.S. Space Force satellite communication contracts.

Money Talk·Jul 20
BC Token Hits Record $0.0179 as Ecosystem Utility Expands
Releases

BC Token Hits Record $0.0179 as Ecosystem Utility Expands

The BC token reached an all-time high of approximately $0.0179 on July 20, marking a 14% surge since its previous peak just three days earlier. This latest price record underscores a steady climb for the BC.GAME ecosystem asset, which has gained over 50% in value since mid-April.

Medtrum Targets German Diabetes Market With 300-Unit Patch Pump
Releases

Medtrum Targets German Diabetes Market With 300-Unit Patch Pump

German patients requiring higher daily insulin doses will soon gain access to Medtrum’s 300U tubeless patch pump. Following a debut at the DDG 2026 conference in Berlin, the device secured a dedicated product code in the national statutory health insurance directory, clearing a critical path for reimbursement and commercial distribution.

Money Talk·Jul 20
Ericsson Accelerates Share Buybacks with 9.6 Million Shares Acquired
Releases

Ericsson Accelerates Share Buybacks with 9.6 Million Shares Acquired

Between July 13 and July 17, 2026, Ericsson repurchased 9,595,000 of its own Class B shares, deploying nearly 945 million Swedish kronor. The aggressive buying spree, executed via Goldman Sachs Bank Europe SE on Nasdaq Stockholm, marks a significant step in the company's 15 billion kronor capital return program.

Shinsung Materials Patents Advanced UV Filter Stabilization
Releases

Shinsung Materials Patents Advanced UV Filter Stabilization

South Korean manufacturer Shinsung Materials has secured a patent for the purification and stabilization of Ecamsule, a high-performance UV-A filter. By refining Terephthalylidene Dicamphor Sulfonic Acid into a high-purity powder, the company is addressing long-standing formulation challenges that previously hindered the ingredient's broader use in global sun care products.

Money Talk·Jul 20
Ericsson spends nearly 1 billion SEK on share buybacks
Releases

Ericsson spends nearly 1 billion SEK on share buybacks

Between July 13 and July 17, 2026, Ericsson repurchased 9,595,000 of its own Class B shares, committing a total of 944.88 million SEK to the effort. The acquisitions, executed on Nasdaq Stockholm by Goldman Sachs Bank Europe SE, mark a significant acceleration in the company’s ongoing capital allocation strategy.

Antengene to Present Clinical Data for ATG-022 and ATG-037 at ESMO 2026
Releases

Antengene to Present Clinical Data for ATG-022 and ATG-037 at ESMO 2026

Antengene Corporation will showcase new clinical findings for its lead oncology candidates during the European Society for Medical Oncology Annual Congress in Madrid this October. The presentations cover Phase 2 results for a Claudin 18.2 antibody-drug conjugate and updated data on a small-molecule inhibitor for resistant melanoma.

X-Bow Unveils Buckler Interceptor to Counter Drone Swarms
Releases

X-Bow Unveils Buckler Interceptor to Counter Drone Swarms

Trading million-dollar missiles against thousand-dollar drones is a losing economic strategy for modern militaries. At the Farnborough International Airshow, X-Bow Systems revealed Buckler, a supersonic interceptor priced under $100,000, designed specifically to break the current cycle of unsustainable costs in defense against Group 3 aerial threats.

Money Talk·Jul 20
Aeromexico to Equip 100-Plane Fleet with Honeywell Runway Safety Tech
Releases

Aeromexico to Equip 100-Plane Fleet with Honeywell Runway Safety Tech

Aeromexico has committed to integrating Honeywell Aerospace’s Surface Alerts (SURF-A) technology across its Boeing 737 NG and 737 MAX fleet. By deploying this system on more than 100 aircraft, the carrier aims to provide flight crews with critical automated warnings to prevent potential collisions during taxi, takeoff, and landing operations.

Squirro Debuts Agent Catalog to Solve Enterprise AI Deployment Stalls
Releases

Squirro Debuts Agent Catalog to Solve Enterprise AI Deployment Stalls

Zurich-based Squirro is launching a catalog of 13 pre-built AI agents designed to break the cycle of starting from scratch with every new implementation. By establishing a shared foundation for security, compliance, and system connectivity, the platform allows companies to reuse infrastructure, significantly accelerating the path from proof-of-concept to production.

Money Talk·Jul 20
Alibaba Faces Investor Investigation Over AI Intellectual Property Claims
Releases

Alibaba Faces Investor Investigation Over AI Intellectual Property Claims

The DJS Law Group has launched an investigation into Alibaba Group Holding Limited following allegations that the company improperly accessed proprietary artificial intelligence technology. The probe centers on whether Alibaba misled shareholders by failing to disclose critical information regarding these potential securities law violations.

Regeneron faces securities fraud class action over clinical trial claims
Releases

Regeneron faces securities fraud class action over clinical trial claims

Investors who purchased Regeneron Pharmaceuticals shares between August 1, 2025, and May 15, 2026, are being urged to join a class action lawsuit. The Schall Law Firm alleges the company misled the market regarding the potential success of its Phase III Fianlimab-Libtayo study, resulting in significant financial losses for shareholders.

Schall Law Firm Targets Planet Fitness in Securities Class Action
Releases

Schall Law Firm Targets Planet Fitness in Securities Class Action

Investors who purchased Planet Fitness stock between November 6, 2025, and May 6, 2026, are being urged to join a class action lawsuit filed by The Schall Law Firm. The litigation alleges the fitness chain misled shareholders regarding its growth trajectory and the efficacy of its national pricing strategies.

Clarivate’s RiskMark Secures 2026 CODiE Award for Legal AI
Releases

Clarivate’s RiskMark Secures 2026 CODiE Award for Legal AI

A digital tool capable of condensing hours of trademark research into minutes has earned top honors, as Clarivate’s RiskMark took home the 2026 CODiE Award for Best AI Tool for Lawyers. The platform leverages predictive and generative technology to navigate the mounting complexity of global intellectual property landscapes.

Money Talk·Jul 20
Aon Scales Data Center Insurance Capacity to $5 Billion
Releases

Aon Scales Data Center Insurance Capacity to $5 Billion

As global demand for artificial intelligence and hyperscale computing drives massive capital investment, Aon has expanded its Data Center Lifecycle Insurance Program to $5 billion. The upgrade aims to provide developers with deeper risk intelligence and broader coverage across the entire lifespan of complex digital infrastructure projects.

Money Talk·Jul 20
Hypershell Launches AI-Driven Exoskeleton Series Across Europe
Releases

Hypershell Launches AI-Driven Exoskeleton Series Across Europe

Hypershell has officially brought its X Series consumer exoskeletons to the European market, introducing a lineup powered by proprietary AI motion control. Verified by TÜV Rheinland for its end-to-end AI capabilities, the gear is designed to provide real-time, intuitive support for hikers, outdoor professionals, and rescue teams alike.

Money Talk·Jul 20
IndiGo taps Honeywell for record-breaking 810-aircraft fleet upgrade
Releases

IndiGo taps Honeywell for record-breaking 810-aircraft fleet upgrade

In a deal marking the largest equipment procurement in its history, Honeywell Aerospace will supply avionics and power systems for IndiGo’s massive expansion of 810 new Airbus A320neo family aircraft. The agreement deepens a decade-long partnership aimed at bolstering the Indian carrier's safety and operational efficiency as it scales globally.

Money Talk·Jul 20
Investors Urged to Join Securities Class Action Against Zoetis
Releases

Investors Urged to Join Securities Class Action Against Zoetis

The Schall Law Firm is rallying shareholders of Zoetis Inc. to join a class action lawsuit following allegations that the veterinary drug manufacturer misled the market. Investors who purchased stock between January 14, 2025, and May 6, 2026, face a July 27, 2026, deadline to seek potential recovery for their losses.

Money Talk·Jul 20
Documentary explores human narratives in the South China Sea
Releases

Documentary explores human narratives in the South China Sea

Amidst rising geopolitical friction, a new documentary from China Media Group offers a departure from state-level disputes by focusing on individual connections to the region. Released on July 12, "South China Sea: Our Story" frames the contested waters through the eyes of those who work, study, and protect them.

Money Talk·Jul 20
Schall Law Firm Targets ADMA Biologics in Securities Fraud Action
Releases

Schall Law Firm Targets ADMA Biologics in Securities Fraud Action

Investors who acquired ADMA Biologics securities between August 9, 2024, and March 25, 2026, face a deadline of August 10, 2026, to join a pending class action lawsuit. The Schall Law Firm alleges the company misled shareholders through undisclosed related-party transactions and deceptive revenue reporting practices.